Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Property, Plant & Equipment (Net) (2021 - 2026)

Analysis

Biohaven (BHVN) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Biohaven 2.37 Bn 2.10 Bn - 15.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.09 Mn
Mar 31, 2026 15.26 Mn
Dec 31, 2025 15.96 Mn
Sep 30, 2025 17.52 Mn
Jun 30, 2025 18.59 Mn
Mar 31, 2025 17.79 Mn
Dec 31, 2024 17.32 Mn
Sep 30, 2024 18.28 Mn
Jun 30, 2024 18.67 Mn
Mar 31, 2024 16.69 Mn
Dec 31, 2023 17.19 Mn
Sep 30, 2023 17.67 Mn
Jun 30, 2023 17.28 Mn
Mar 31, 2023 17.49 Mn
Dec 31, 2022 17.51 Mn
Sep 30, 2022 17.42 Mn
Dec 31, 2021 13.01 Mn